Search Results - Narsis Attar
- Showing 1 - 9 results of 9
-
1
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer by Narsis Attar, Siavash K. Kurdistani
Published 2016Revisão -
2
-
3
-
4
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway by Mohammad Atefi, Erika von Euw, Narsis Attar, Charles Ng, Connie Chu, Deliang Guo, Ramin Nazarian, Bartosz Chmielowski, John A. Glaspy, Begonya Comin-Anduix, Paul S. Mischel, Roger S. Lo, Antoni Ribas
Published 2011Artigo -
5
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations by Franziska Niehr, Erika von Euw, Narsis Attar, Deliang Guo, Doug Matsunaga, Hooman Sazegar, Charles Ng, John A. Glaspy, Juan A. Recio, Roger S. Lo, Paul S. Mischel, Begonya Comin-Anduix, Antoni Ribas
Published 2011Artigo -
6
The histone H3-H4 tetramer is a copper reductase enzyme by Narsis Attar, Oscar A. Campos, Maria Vogelauer, Chen Cheng, Yong Xue, Stefan Schmollinger, Łukasz Salwiński, Nathan V. Mallipeddi, Brandon A. Boone, Linda Yen, Sichen Yang, Shannon Zikovich, Jade Dardine, Michael Carey, Sabeeha Merchant, Siavash K. Kurdistani
Published 2020Artigo -
7
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines by Erika von Euw, Mohammad Atefi, Narsis Attar, Connie Chu, Sybil Zachariah, Barry L. Burgess, Stephen Mok, Charles Ng, Deborah J. Wong, Bartosz Chmielowski, David I. Lichter, Richard C. Koya, Tara A. McCannel, Elena S. Izmailova, Antoni Ribas
Published 2012Artigo -
8
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation by Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C. Koya, Hane Lee, Zugen Chen, Mi‐Kyung Lee, Narsis Attar, Hooman Sazegar, Thinle Chodon, Stanley F. Nelson, Grant A. McArthur, Jeffrey A. Sosman, Antoni Ribas, Roger S. Lo
Published 2010Artigo -
9
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032 by Jonas Nørskov Søndergaard, Ramin Nazarian, Qi Wang, Deliang Guo, Teli Hsueh, Stephen Mok, Hooman Sazegar, Laura E. MacConaill, Jordi Barretina, Sarah M. Kehoe, Narsis Attar, Erika von Euw, Jonathan E. Zuckerman, Bartosz Chmielowski, Begoña Comı́n-Anduix, Richard C. Koya, Paul S. Mischel, Roger S. Lo, Antoni Ribas
Published 2010Artigo
Search Tools:
Related Subjects
Biology
Cell biology
Cancer research
Genetics
MAPK/ERK pathway
Melanoma
Cell culture
Gene
KRAS
Kinase
Medicine
Neuroblastoma RAS viral oncogene homolog
Biochemistry
Cell
Chemistry
Mutation
Cancer
Colorectal cancer
Internal medicine
MEK inhibitor
Metastatic melanoma
Molecular biology
Mutant
PI3K/AKT/mTOR pathway
Pharmacology
Signal transduction
V600E
Vemurafenib
AMPK
Antibody